E. Petit

ORCID: 0009-0004-8732-3554 · 27 papers in corpus
article 2026
·doi:10.1016/s1634-7358(26)51482-7
other 2025
JMIR formative research ·doi:10.2196/58262

BACKGROUND: After experiencing symptoms for an average of 7 years before diagnosis, patients with endometriosis are usually left with more questions than answers about managing their symptoms in the absence of a cure. To help women with end…

article 2025
Journal of women's health (2002) ·doi:10.1177/15409996251380129

BACKGROUND: An average time to diagnosis of 7 years is commonly described for endometriosis; diagnostic delay for adenomyosis is unknown. This cross-sectional study aimed to describe diagnostic delay for endometriosis and adenomyosis and to…

article 2025
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2025.102950

BACKGROUND: Endometriosis is a common pathology that can lead to a decrease in fertility and is therefore a medical indication for preserving fertility. Traditionally, gonadotropin-releasing hormone (GnRH) antagonist and agonist protocols a…

article 2025
NEJM evidence ·doi:10.1056/evidoa2400195

BACKGROUND: Diagnosis of endometriosis is a challenge. The recent development of a saliva-based micro-ribonucleic acid (miRNA) signature for the diagnosis of endometriosis may enable a timelier and less invasive approach, but this requires …

preprint 2024
·doi:10.2196/preprints.58262

BACKGROUND After experiencing symptoms for an average of 7 years before diagnosis, patients with endometriosis are usually left with more questions than answers about managing their symptoms in the absence of a cure. To help women with end…

review 2024
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.15840

Endometriosis is a complex gynecologic disorder characterized primarily by symptoms of pelvic pain, infertility, and altered quality of life. National and international guidelines highlight the diagnostic difficulties and lack of conclusive…

preprint 2024
·doi:10.2139/ssrn.4985332
article 2023
NEJM evidence ·doi:10.1056/evidoa2200282

BACKGROUND: The discovery of a saliva-based micro–ribonucleic acid (miRNA) signature for endometriosis in 2022 opened up new perspectives for early and noninvasive diagnosis of the disease. The 109-miRNA saliva signature is the product of m…

book-chapter 2020
·doi:10.1016/b978-2-294-76781-4.00001-6
book-chapter 2020
·doi:10.1016/b978-2-294-76781-4.00006-5
book-chapter 2020
·doi:10.1016/b978-2-294-76781-4.00003-x
book-chapter 2020
·doi:10.1016/b978-2-294-76781-4.00005-3
article 2018
·doi:10.1016/s1634-7358(18)41323-x
article 2018
·doi:10.1016/s1636-5410(18)41301-3
review 2018
Gynecologie, obstetrique, fertilite & senologie ·doi:10.1016/j.gofs.2018.02.007

Management of deep pelvic and digestive endometriosis can lead to colorectal resection and anastomosis. Colorectal anastomosis carries risks for dreaded infectious and functional morbidity. The aim of the study was to establish, regarding t…

review 2018
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2018.06.009

Endometriosis is a condition where hormonal-responsive endometrial tissue grows outside the uterus usually within the pelvic cavity. Extra-pelvic endometriosis is rare and may involve the pericardium. We report the first case of pericardial…

article 2017
·doi:10.1016/s1636-5410(16)81800-0
article 2017
·doi:10.1016/j.femme.2017.01.001
article 2017
·doi:10.1016/j.femme.2017.10.003
article 2016
·doi:10.1016/j.femme.2016.06.001
article 2016
·doi:10.1016/j.femme.2016.02.001
article 2014
·doi:10.1016/j.femme.2013.12.002
article 2013
·doi:10.1016/j.femme.2013.07.001
article 2013